The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders

The 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. One of the most common and most confusing, in terms of overlapping symptoms and interfering treatments is the presence of significant lung disorders. In this article is reviewed what the recent guid...

Full description

Bibliographic Details
Main Author: Andrew JS Coats
Format: Article
Language:English
Published: Barcaray International 2017-01-01
Series:International Cardiovascular Forum Journal
Subjects:
Online Access:http://icfjournal.org/index.php/icfj/article/view/454/454
id doaj-b76f4d1f98444d0889678b5c3068bcb0
record_format Article
spelling doaj-b76f4d1f98444d0889678b5c3068bcb02020-11-25T00:25:00ZengBarcaray InternationalInternational Cardiovascular Forum Journal2410-26362409-34242017-01-01107374https://doi.org/10.17987/icfj.v10i0.454The Management of Co-Morbidities in Patients with Heart Failure – Lung DisordersAndrew JS Coats0Monash University, Australia and University of Warwick, UKThe 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. One of the most common and most confusing, in terms of overlapping symptoms and interfering treatments is the presence of significant lung disorders. In this article is reviewed what the recent guidelines say about the management of lung disorders in the setting of HF, both HFrEF and HFpEF and expand on some of the practical advice.http://icfjournal.org/index.php/icfj/article/view/454/454CardiologyHeart failureLung diseaseGuidelines
collection DOAJ
language English
format Article
sources DOAJ
author Andrew JS Coats
spellingShingle Andrew JS Coats
The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
International Cardiovascular Forum Journal
Cardiology
Heart failure
Lung disease
Guidelines
author_facet Andrew JS Coats
author_sort Andrew JS Coats
title The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
title_short The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
title_full The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
title_fullStr The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
title_full_unstemmed The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
title_sort management of co-morbidities in patients with heart failure – lung disorders
publisher Barcaray International
series International Cardiovascular Forum Journal
issn 2410-2636
2409-3424
publishDate 2017-01-01
description The 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. One of the most common and most confusing, in terms of overlapping symptoms and interfering treatments is the presence of significant lung disorders. In this article is reviewed what the recent guidelines say about the management of lung disorders in the setting of HF, both HFrEF and HFpEF and expand on some of the practical advice.
topic Cardiology
Heart failure
Lung disease
Guidelines
url http://icfjournal.org/index.php/icfj/article/view/454/454
work_keys_str_mv AT andrewjscoats themanagementofcomorbiditiesinpatientswithheartfailurelungdisorders
AT andrewjscoats managementofcomorbiditiesinpatientswithheartfailurelungdisorders
_version_ 1725350364048261120